• Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Rating of "Moderate Buy" by Analysts

    Источник: Buzz FX / 21 фев 2025 02:36:12   America/New_York


    Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat February 21, 2025 Share Link copied to clipboard. Shares of Iovance Biotherapeutics, Inc.
    Read more...
Опубликовать